Evidence map›Paper›PMID 32030847›Full record

ArticleJournal of genetic counseling2020

Adult patients with undiagnosed conditions and their responses to unresolved uncertainty from exome sequencing.

Ahna Neustadt, Jill Owczarzak, Weiyi Mu, Julie S Cohen, Lori Erby

Open access · greenAbstract read
In one paragraph

Article in Journal of genetic counseling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Navigating an Uninformative Genomic Test Result: A Practical Guide.Journal of paediatrics and child health · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ahna NeustadtDepartment of Health, Behavior, & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0003-2114-1462
Jill OwczarzakDepartment of Health, Behavior, & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Weiyi MuMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland.
Julie S CohenDepartment of Neurology & Developmental Medicine, Kennedy Krieger Institute, Baltimore, Maryland.
Lori ErbyDepartment of Health, Behavior, & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Johns Hopkins University · USNational Institutes of Health · USKennedy Krieger Institute · US

Funding

NHGRI/DIR Genetic Counseling Training ProgramZIEHG200353 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ERBY, LORI · 2010 to 2025
$16.9M
Intramural NIH HHS ZIE HG200353
6 · The paper itself

Abstract

Patients pursuing exome sequencing (ES) in their quest for diagnosis will most often experience unresolved uncertainty from their ES results because the majority of ES results are non-diagnostic. This study explored and compared the experiences of receiving two types of ES results that may result in diagnostic uncertainty. Semi-structured phone interviews were conducted with 23 adult patients with undiagnosed conditions who received either a negative result or a result with one or more variants of uncertain significance (VUSs) from ES. Interviews were transcribed and subjected to thematic and comparative analyses. Participants accurately understood their results and described various sources of genomic uncertainty including probability, complexity, and ambiguity. Their acclimation to illness uncertainty resulted in realistic expectations about and acceptance of their results. Participants still hoped that ES would end their diagnostic odyssey. Hope and optimism were used to cope with continued uncertainty. No thematic differences were found between the experiences of those who received negative results versus those who received VUSs. Our findings may inform clinical practices of informed consent and disclosure of negative results and VUSs through a greater consideration of patients' reactions, concerns, and challenges with adaptation to uncertainty.

Indexed as

Exome SequencingUncertaintyAdaptation, PsychologicalAdultDisclosureFemaleGenetic TestingHumansInformed ConsentMaleMiddle Agedattitudesbeliefsexome sequencinggenetic counselinglived experiencenegativeuncertainundiagnosedvariant of uncertain significance (VUS)

Identifiers

PMID32030847
PMCPMC10150798
OpenAlexW3005138463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.